PCV40 COST-EFFECTIVENESS OF TARGETING MULTIPLE LIPID PARAMETERS (LDL-C, HDL-C, TG) WITH NIASPANVERSUS A SINGLE LIPID PARAMETER (LDL-C) WITH ZETIA IN PATIENTS RECEIVING ON-GOING STATIN THERAPY
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66338-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)66338-3/fulltext
Title :
PCV40 COST-EFFECTIVENESS OF TARGETING MULTIPLE LIPID PARAMETERS (LDL-C, HDL-C, TG) WITH NIASPANVERSUS A SINGLE LIPID PARAMETER (LDL-C) WITH ZETIA IN PATIENTS RECEIVING ON-GOING STATIN THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66338-3&doi=10.1016/S1098-3015(10)66338-3
First page :
Section Title :
Open access? :
No
Section Order :
172